We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Lipoxen | LSE:LPX | London | Ordinary Share | GB00B08NWV55 | ORD 0.5P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 7.875 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
TIDMLPX
RNS Number : 6633K
Lipoxen PLC
23 April 2010
+---------------------------------+---------------------------------+
| For immediate release | 23 April 2010 |
+---------------------------------+---------------------------------+
Lipoxen PLC
('Lipoxen' or 'the Company')
DIRECTOR DEALING
Lipoxen PLC (AIM: LPX), a bio-pharmaceutical company specialising in the
development of high-value differentiated biologicals, vaccines and siRNA
delivery, is pleased to announce that further to the announcement released on 1
April 2010, that the Company has raised GBP1.2 million through a non pre-emptive
issue of shares (the "Fundraising"), certain directors have acquired ordinary
shares of 0.5 pence each (the "New Ordinary Shares"). Details of the director
dealings are set out in the table below:
+--------------+----------+-----------+-----------+----------+
| Name | Date | Shares | Total | % of |
| | | acquired | interest | total |
| | | | | issued |
| | | | | share |
| | | | | capital |
+--------------+----------+-----------+-----------+----------+
| Sir Brian | 1 April | 1,071,429 | 2,262,606 | 1.32 |
| Richards | 2010 | | | |
+--------------+----------+-----------+-----------+----------+
| Scott | 1 April | 535,714 | 1,301,362 | 0.76 |
| Maguire | 2010 | | | |
+--------------+----------+-----------+-----------+----------+
| Colin Hill | 1 April | 535,714 | 1,675,420 | 0.97 |
| | 2010 | | | |
+--------------+----------+-----------+-----------+----------+
| | | | | |
+--------------+----------+-----------+-----------+----------+
- Ends -
For further information please contact:
+------------------------------------------+--------------------+
| Lipoxen plc | +44 (0)20 7389 |
| | 5015 |
+------------------------------------------+--------------------+
| M. Scott Maguire, Chief Executive | |
| Officer | |
+------------------------------------------+--------------------+
| | |
+------------------------------------------+--------------------+
| Singer Capital Markets (nominated | +44 (0)20 3205 |
| adviser) | 7500 |
+------------------------------------------+--------------------+
| Jeff Keating / Claes Spång | |
+------------------------------------------+--------------------+
| | |
+------------------------------------------+--------------------+
| Buchanan Communications | +44 (0)20 7466 |
| | 5000 |
+------------------------------------------+--------------------+
| Lisa Baderoon / Catherine Breen | |
+------------------------------------------+--------------------+
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSKMGZDVZZGGZM
1 Year Lipoxen Chart |
1 Month Lipoxen Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
